Literature DB >> 19653990

Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry.

Kristin R Wildsmith1, Bomie Han, Randall J Bateman.   

Abstract

Using apolipoprotein E (ApoE) as a model protein, we developed a protein isoform analysis method utilizing stable isotope labeling tandem mass spectrometry (SILT MS). ApoE isoforms are quantitated using the intensities of the b and y ions of the (13)C-labeled tryptic isoform-specific peptides versus unlabeled tryptic isoform-specific peptides. The ApoE protein isoform analysis using SILT allows for the simultaneous detection and relative quantitation of different ApoE isoforms from the same sample. This method provides a less biased assessment of ApoE isoforms compared to antibody-dependent methods, and may lead to a better understanding of the biological differences between isoforms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653990      PMCID: PMC2749897          DOI: 10.1016/j.ab.2009.07.049

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  17 in total

1.  Proteome dynamics in complex organisms: using stable isotopes to monitor individual protein turnover rates.

Authors:  Mary K Doherty; Colin Whitehead; Heather McCormack; Simon J Gaskell; Robert J Beynon
Journal:  Proteomics       Date:  2005-02       Impact factor: 3.984

2.  Assessing reproducibility of a protein dynamics study using in vivo labeling and liquid chromatography tandem mass spectrometry.

Authors:  Henrik Molina; Giovanni Parmigiani; Akhilesh Pandey
Journal:  Anal Chem       Date:  2005-05-01       Impact factor: 6.986

3.  Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.

Authors:  Randall J Bateman; Ling Y Munsell; John C Morris; Robert Swarm; Kevin E Yarasheski; David M Holtzman
Journal:  Nat Med       Date:  2006-06-25       Impact factor: 53.440

4.  Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.

Authors:  Masayuki Morikawa; John D Fryer; Patrick M Sullivan; Erin A Christopher; Suzanne E Wahrle; Ronald B DeMattos; Mark A O'Dell; Anne M Fagan; Hilal A Lashuel; Thomas Walz; Kiyofumi Asai; David M Holtzman
Journal:  Neurobiol Dis       Date:  2005 Jun-Jul       Impact factor: 5.996

Review 5.  Apolipoprotein E structure: insights into function.

Authors:  Danny M Hatters; Clare A Peters-Libeu; Karl H Weisgraber
Journal:  Trends Biochem Sci       Date:  2006-07-03       Impact factor: 13.807

6.  In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.

Authors:  Regina E Dinkel; P Hugh R Barrett; Thomas Demant; Klaus G Parhofer
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-11-02       Impact factor: 4.222

7.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Authors:  E H Corder; A M Saunders; N J Risch; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

8.  A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.

Authors:  Randall J Bateman; Eric R Siemers; Kwasi G Mawuenyega; Guolin Wen; Karen R Browning; Wendy C Sigurdson; Kevin E Yarasheski; Stuart W Friedrich; Ronald B Demattos; Patrick C May; Steven M Paul; David M Holtzman
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

9.  APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Authors:  Hiroaki Fukumoto; Martin Ingelsson; Nina Gårevik; Lars Olof Wahlund; Nobuyuki Nukina; Yoshio Yaguchi; Masao Shibata; Bradley T Hyman; G William Rebeck; Michael C Irizarry
Journal:  Exp Neurol       Date:  2003-09       Impact factor: 5.330

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  14 in total

1.  15N-labeled full-length apolipoprotein E4 as an internal standard for mass spectrometry quantification of apolipoprotein E isoforms.

Authors:  Meiyao Wang; Junjun Chen; Illarion V Turko
Journal:  Anal Chem       Date:  2012-09-11       Impact factor: 6.986

2.  Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma.

Authors:  Alaina T Baker-Nigh; Kwasi G Mawuenyega; James G Bollinger; Vitaliy Ovod; Tom Kasten; Erin E Franklin; Fan Liao; Hong Jiang; David Holtzman; Nigel J Cairns; John C Morris; Randall J Bateman
Journal:  J Biol Chem       Date:  2016-10-28       Impact factor: 5.157

3.  Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.

Authors:  Ilijana Begcevic Brkovic; Benedikt Zöhrer; Markus Scholz; Madlen Reinicke; Julia Dittrich; Surab Kamalsada; Ronny Baber; Frank Beutner; Andrej Teren; Christoph Engel; Kerstin Wirkner; Holger Thiele; Markus Löffler; Steffi G Riedel-Heller; Uta Ceglarek
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

4.  Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion.

Authors:  Rebecca R Miles; William Perry; Joseph V Haas; Marian K Mosior; Mathias N'Cho; Jian W J Wang; Peng Yu; John Calley; Yong Yue; Quincy Carter; Bomie Han; Patricia Foxworthy; Mark C Kowala; Timothy P Ryan; Patricia J Solenberg; Laura F Michael
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

5.  Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

Authors:  Valentin Blanchard; Stéphane Ramin-Mangata; Stéphanie Billon-Crossouard; Audrey Aguesse; Manon Durand; Kevin Chemello; Brice Nativel; Laurent Flet; Maud Chétiveaux; David Jacobi; Jean-Marie Bard; Khadija Ouguerram; Gilles Lambert; Michel Krempf; Mikaël Croyal
Journal:  J Lipid Res       Date:  2018-03-14       Impact factor: 5.922

6.  Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides.

Authors:  Romain Simon; Marion Girod; Catherine Fonbonne; Arnaud Salvador; Yohann Clément; Pierre Lantéri; Philippe Amouyel; Jean Charles Lambert; Jérôme Lemoine
Journal:  Mol Cell Proteomics       Date:  2012-08-23       Impact factor: 5.911

7.  Lesson from the stoichiometry determination of the cohesin complex: a short protease mediated elution increases the recovery from cross-linked antibody-conjugated beads.

Authors:  Johann Holzmann; Johannes Fuchs; Peter Pichler; Jan-Michael Peters; Karl Mechtler
Journal:  J Proteome Res       Date:  2010-11-18       Impact factor: 4.466

8.  In vivo human apolipoprotein E isoform fractional turnover rates in the CNS.

Authors:  Kristin R Wildsmith; Jacob M Basak; Bruce W Patterson; Yuriy Pyatkivskyy; Jungsu Kim; Kevin E Yarasheski; Jennifer X Wang; Kwasi G Mawuenyega; Hong Jiang; Maia Parsadanian; Hyejin Yoon; Tom Kasten; Wendy C Sigurdson; Chengjie Xiong; Alison Goate; David M Holtzman; Randall J Bateman
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Human apolipoprotein e resequencing by proteomic analysis and its application to serotyping.

Authors:  Motoi Nishimura; Mamoru Satoh; Satomi Nishimura; Shoko Kakinuma; Kenichi Sato; Setsu Sawai; Sachio Tsuchida; Takeshi Kazama; Kazuyuki Matsushita; Sayaka Kado; Yoshio Kodera; Fumio Nomura
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

10.  Advantageous uses of mass spectrometry for the quantification of proteins.

Authors:  John E Hale
Journal:  Int J Proteomics       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.